Glucosum Teva

Glucosum Teva is a sterile intravenous injection solution that contains glucose as its active ingredient. It is supplied in a standard concentration (strength not specified) and is classified as a carbohydrate solution used as an excipient. Marketed in the European Union and available by prescription, Glucosum Teva provides a rapid source of glucose for patients who require intravenous energy support or fluid replacement in clinical settings.

Glucosum Teva is indicated for several clinical situations where rapid elevation of plasma glucose or fluid replacement is required.

- Treatment of acute hypoglycemia when oral glucose is not feasible. - Component of parenteral nutrition regimens for patients unable to eat or absorb nutrients. - Fluid and electrolyte replacement in peri‑operative or critical‑care settings. - Dilution medium for certain intravenous medications that require a carbohydrate carrier. - Supportive therapy during prolonged fasting or severe malnutrition.

Adverse reactions to Glucosum Teva are generally related to the intravenous administration of a glucose solution.

Common: - Mild hyperglycemia or transient rise in blood glucose levels. - Local irritation or pain at the injection site. - Nausea or mild gastrointestinal discomfort.

Serious: - Severe hyperglycemia with possible osmotic diuresis. - Electrolyte imbalance, particularly hyponatremia or hyperkalemia. - Allergic reaction ranging from urticaria to anaphylaxis.

When using Glucosum Teva, clinicians should consider several safety factors to minimize risk.

- Assess baseline blood glucose and monitor levels during and after infusion. - Adjust dosage in patients with diabetes mellitus or impaired glucose tolerance. - Use caution in individuals with renal or hepatic dysfunction, as metabolism may be altered. - Avoid rapid infusion in neonates and infants to prevent circulatory overload. - Ensure proper aseptic technique to reduce the risk of infection. - Review electrolyte status before administration, especially in patients receiving large volumes.

Glucosum Teva may interact with other agents that affect glucose metabolism or fluid balance.

Avoid: - Concurrent use of high‑dose insulin without appropriate glucose monitoring. - Co‑administration with other hypertonic glucose solutions, which can exacerbate hyperglycemia.

Use with caution: - Diuretic therapy that may influence electrolyte levels. - Beta‑blockers, which can mask symptoms of hypoglycemia. - Corticosteroids, as they may increase glucose production. - Medications that cause fluid retention, such as certain antihypertensives.